As many as four percent of the world’s population lives with an autoimmune disease, in which the immune system fails to distinguish between ‘self’ and ‘non-self’ and mistakenly attacks the body, ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) treatment aims to slow immune-driven demyelination and reduce inflammation. This can help protect nerve signaling and function. First-line CIDP ...
Hosted on MSN
How to manage chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in the workplace
When you live with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), your symptoms may pose certain challenges at work. But in many cases, asking your employer for appropriate ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) results in disability through immune-mediated nerve injury, which can lead to irreversible deficits after the inflammatory component of CIDP is ...
The last time I spoke about Dianthus Therapeutics, Inc. (DNTH), it was in a Seeking Alpha article entitled "Dianthus: Improved Autoimmune Disorder Targeting With Classical Pathway Inhibition." With ...
This week, we are going to continue down the road of autoimmune peripheral nerve conditions to discuss two that we have touched on in the past—Guillain-Barré Syndrome and CIDP (chronic inflammatory ...
DUBLIN--(BUSINESS WIRE)--The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results